

[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
Brian Skorney Downgraded (VYGR) to Hold and Decreased Target to $6 on, Feb 26th, 2021
Brian Skorney of Baird, Downgraded "Voyager Therapeutics, Inc." (VYGR) to Hold and Decreased Target from $18 to $6 on, Feb 26th, 2021.
Brian has made no other calls on VYGR in the last 4 months.
There are 5 other peers that have a rating on VYGR. Out of the 5 peers that are also analyzing VYGR, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $7 on, Wednesday, February 3rd, 2021
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $6 on, Wednesday, February 3rd, 2021
- Thomas Shrader of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, February 3rd, 2021
- Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, November 11th, 2020
This is the rating of the analyst that currently disagrees with Brian
- Reni Benjamin of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $17 on, Tuesday, November 10th, 2020
Contributing Sources